0.2550CAD+6.25%Mkt Cap: 51.22M $P/E: —1d ago
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United…
Indicators:|
Key Statistics
Company
Market Cap51.22M $
Enterprise Value54.49M $
Revenue (TTM)624.78K $
Gross Profit369.32K $
Net Income (TTM)-3.00M $
Revenue/Share0.0022 USD
Last Price0.2550 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-25.50
PEG—
EV/EBITDA-21.06
EV/Revenue87.22
P/S87.88
P/B36.43
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.150040% of range0.4100
52W High0.4100 CAD
52W Low0.1500 CAD
Profitability
Gross Margin62.11%
Oper. Margin-776.89%
EBITDA Margin0.00%
Profit Margin-504.71%
ROE-231.79%
ROA-117.92%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.39M $
CapEx (TTM)35.64K $
FCF Margin-225.13%
FCF Yield-2.75%
Net Debt-416.83K $
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity0.26
Current Ratio1.37
Quick Ratio1.01
Book Value/Sh0.0070 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.7000 CAD
Upside (mean)+174.5%
Target Range0.7000 CAD – 0.7000 CAD
# Analysts1
Ownership
Shares Out.275.82M
Float276.45M
Insiders8.40%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short63.53K
Short (prev mo.)5.69M
Technical
SMA 500.2606 (-2.1%)
SMA 2000.2366 (+7.8%)
Beta0.60
S&P 52W Chg20.05%
Avg Vol (30d)230.63K
Avg Vol (10d)72.25K
Technical Indicators
RSI (14)57.4
MACD-0.0026
MACD Signal-0.0059
MACD Hist.+0.0033
BB Upper0.2491 CAD
BB Middle0.2350 CAD
BB Lower0.2209 CAD
BB Width12.04%
ATR (14)0.0155 CAD
Vol Ratio (20d)1.22x